Spineart and eCential Robotics announce FDA clearance of PERLA® App for use with Op.nTM robotic navigation platform
Spineart and eCential Robotics announce FDA clearance of PERLA® App for use with Op.nTM robotic navigation platform
Dallas, Texas and Franklin, Tennessee, March 13, 2025 — Spineart, a fast-growing company in spine surgery innovation, and eCential Robotics, an expert company in surgical robotics, proudly announce the 510(k) clearance from the U.S. Food and Drug Administration (FDA) of the Spineart PERLA® TL application (PERLA® App) for use with the new eCential Robotics Op.nTM robotic navigation platform. This clearance marks a significant milestone in advancing robotic-assisted spine surgery and demonstrating new ways to innovate by combining Spineart’s and eCential Robotics’ expertise.
